Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stacey A Cohen

Showing results (21-30 of 52) with videos related to

Pageof 6
Sort By:
Cancers|June 2, 2021
Colorectal Cancer Anatomical Site and Sleep QualityMimi Ton, Nathaniel F Watson, Arthur Sillah, et al.
Contemporary Clinical Trials Communications|May 17, 2021
SWOG S1820: Altering Intake, Managing Symptoms for bowel dysfunction in survivors of Rectal Cancer (The AIMS-RC intervention trial)Virginia Sun, Tracy E Crane, Kathryn B Arnold, et al.
Clinical Epigenetics|May 5, 2017
The CpG island methylator phenotype is concordant between primary colorectal carcinoma and matched distant metastasesStacey A Cohen, Ming Yu, Kelsey Baker, et al.
Epigenetics|April 12, 2022
Evaluation of methylated DCR1 as a biomarker for response to adjuvant irinotecan-based therapy in stage III colon cancer: cancer and leukaemia Group B 89803 (Alliance)Lynn Symonds, Ming Yu, YuHong Zhang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2017
Timing of Aspirin and Other Nonsteroidal Anti-Inflammatory Drug Use Among Patients With Colorectal Cancer in Relation to Tumor Markers and SurvivalXinwei Hua, Amanda I Phipps, Andrea N Burnett-Hartman, et al.
Cancer|October 20, 2015
Initiation of universal tumor screening for Lynch syndrome in colorectal cancer patients as a model for the implementation of genetic information into clinical oncology practiceStacey A Cohen, Mercy Laurino, Deborah J Bowen, et al.
Clinical Colorectal Cancer|December 26, 2015
Evaluation of CpG Island Methylator Phenotype as a Biomarker in Colorectal Cancer Treated With Adjuvant OxaliplatinStacey A Cohen, Chen Wu, Ming Yu, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 30, 2015
Clinicopathologic Risk Factor Distributions for MLH1 Promoter Region Methylation in CIMP-Positive TumorsA Joan Levine, Amanda I Phipps, John A Baron, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 22, 2024
Baseline characteristics and recruitment for SWOG S1820: altering intake, managing bowel symptoms in survivors of rectal cancer (AIMS-RC)Virginia Sun, Cynthia A Thomson, Tracy E Crane, et al.
Journal of the National Cancer Institute|July 22, 2021
Cancer Misinformation and Harmful Information on Facebook and Other Social Media: A Brief ReportSkyler B Johnson, Matthew Parsons, Tanya Dorff, et al.
Pageof 6

Showing results (21-30 of 52) with videos related to

Sort By:
Pageof 6
Cancers|June 2, 2021
Colorectal Cancer Anatomical Site and Sleep QualityMimi Ton, Nathaniel F Watson, Arthur Sillah, et al.
Contemporary Clinical Trials Communications|May 17, 2021
SWOG S1820: Altering Intake, Managing Symptoms for bowel dysfunction in survivors of Rectal Cancer (The AIMS-RC intervention trial)Virginia Sun, Tracy E Crane, Kathryn B Arnold, et al.
Clinical Epigenetics|May 5, 2017
The CpG island methylator phenotype is concordant between primary colorectal carcinoma and matched distant metastasesStacey A Cohen, Ming Yu, Kelsey Baker, et al.
Epigenetics|April 12, 2022
Evaluation of methylated DCR1 as a biomarker for response to adjuvant irinotecan-based therapy in stage III colon cancer: cancer and leukaemia Group B 89803 (Alliance)Lynn Symonds, Ming Yu, YuHong Zhang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2017
Timing of Aspirin and Other Nonsteroidal Anti-Inflammatory Drug Use Among Patients With Colorectal Cancer in Relation to Tumor Markers and SurvivalXinwei Hua, Amanda I Phipps, Andrea N Burnett-Hartman, et al.
Cancer|October 20, 2015
Initiation of universal tumor screening for Lynch syndrome in colorectal cancer patients as a model for the implementation of genetic information into clinical oncology practiceStacey A Cohen, Mercy Laurino, Deborah J Bowen, et al.
Clinical Colorectal Cancer|December 26, 2015
Evaluation of CpG Island Methylator Phenotype as a Biomarker in Colorectal Cancer Treated With Adjuvant OxaliplatinStacey A Cohen, Chen Wu, Ming Yu, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 30, 2015
Clinicopathologic Risk Factor Distributions for MLH1 Promoter Region Methylation in CIMP-Positive TumorsA Joan Levine, Amanda I Phipps, John A Baron, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 22, 2024
Baseline characteristics and recruitment for SWOG S1820: altering intake, managing bowel symptoms in survivors of rectal cancer (AIMS-RC)Virginia Sun, Cynthia A Thomson, Tracy E Crane, et al.
Journal of the National Cancer Institute|July 22, 2021
Cancer Misinformation and Harmful Information on Facebook and Other Social Media: A Brief ReportSkyler B Johnson, Matthew Parsons, Tanya Dorff, et al.
Pageof 6